CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOdense University Hospital

About this trial

The aim of this study is to evaluate the effects of coronary thrombus modification on preventing the microvascular damage associated with primary percutaneous coronary intervention (PCI), and to limit the associated myocardial damage assessed by myocardial salvage index after 3 months. Furthermore, the project will evaluate coronary microvascular damage assessed invasively using both continuous and bolus thermodilution before and after stent implantation. In addition, the project will evaluate the diagnostic ability and associations of pre-stenting invasive physiological measurement to cardiac magnetic resonance imaging measurements.

Eligibility criteria

Qualifiers

ST-elevation at the J-junction in a minimum of two contiguous ECG leads with a minimum of ≥ 0.1 mV in all leads, except for V2 and V3 (which required ≥ 0.2 for men ≥ 40 years old, ≥ 0.25 in men < 40 years old, or ≥ 0.15 mV for all women) or new left bundle branch

Admission to hospital within 12 hours of symptom debut

Angiographic signs of a culprit lesion planned to be treated with primary percutaneous coronary intervention

Disqualifiers

Age < 18 years or inability to provide informed consent

Life expectancy of < 12 months

Hemodynamically instability

Pregnancy or breastfeeding

Trial design

Treatments tested in this trial

  • Coronary thrombus modification
  • Standard stent implantation

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators